Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic
Look for yet another player working in the immuno-oncology space to enter the clinic with a nimble team of experienced execs focused on dismantling immunosuppression …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
